BAYRY News and Press, Bayer AG ADR From 02/18/24

2024-02-18 11:30:00 ET Summary Broyhill Asset Management is a boutique investment firm guided by a disciplined value orientation. We operate outside of the fray and invest with a rational, objective, long-term perspective. The largest contributors to the portfolio's performance fo...

2024-02-11 01:25:00 ET Summary I-Mab Hangzhou will acquire rights to I-Mab’s drug assets in Greater China for $80 M. Anbogen Therapeutics raised $12.5M in a Series A funding round. to advance its two lead drug candidates. Bayer signed a non-binding Letter of Intent to m...

2024-02-06 06:39:02 ET Summary Palantir Technologies surges after reporting strong Q4 results, with revenue exceeding expectations. U.S. appeals court rejects Bayer's argument to dismiss Roundup lawsuit, potentially increasing liability for the company. Layoffs continue to imp...

2024-02-05 17:54:11 ET More on Bayer Bayer Isn't Dead Breaking Up Bayer? Probably Not! Bayer Q3 2023 Results - Earnings Call Presentation Read the full article on Seeking Alpha For further details see: U.S. appeals court refuses to shield Bayer fr...

2024-02-02 07:13:00 ET More on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Inc. (REGN) 42nd Annual JPMorgan Healthcare Conference - (Transcript) Why I Expect Regeneron To Keep Delivering For Investors In 2024 (Upgrade) Regeneron Pharmaceuticals Inc. (REGN) Am...

2024-01-29 13:12:44 ET More on Bayer AG Bayer Isn't Dead Breaking Up Bayer? Probably Not! Bayer Aktiengesellschaft 2023 Q3 - Results - Earnings Call Presentation Bayer slapped with $2.25B Roundup cancer verdict, lawyer says Bayer backs off potential b...

2024-01-27 12:10:00 ET Summary Palm Harbour Capital LLP is a United Kingdom Limited Liability Partnership based in London. We scour the globe seeking undervalued securities in order to build a unique portfolio. The fund was down -4.3% in October and then up +3.96% in November and ...

2024-01-26 17:22:59 ET More on Bayer Bayer Isn't Dead Breaking Up Bayer? Probably Not! Bayer Q3 2023 Results - Earnings Call Presentation Read the full article on Seeking Alpha For further details see: Bayer slapped with $2.2B Roundup cancer verdi...

2024-01-26 15:14:24 ET More on Recursion Pharmaceuticals Recursion Pharmaceuticals: More Hype Than Substance Amid Signs Of Progress Recursion Pharmaceuticals: Second Half 2024 Data Readouts Are Major Inflection Points Recursion Pharma spikes after licensing deal with...

2024-01-18 07:32:22 ET More on Bayer Bayer Isn't Dead Breaking Up Bayer? Probably Not! Bayer Q3 2023 Results - Earnings Call Presentation For further details see: Bayer backs off potential breakup despite investor pressure - Bloomberg